NCT02172456View on ClinicalTrials.gov

Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

October 31, 2002

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

99mTc-radiolabelled tiotropium

DRUG

non-radiolabelled tiotropium

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02172456 - Evaluation of the Lung Deposition Rate and Distribution Pattern of Tiotropium Via HandiHalerTM in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter